this is from the news report in 2010 for cbio, the day of their ASX debut (when their price jumped off a cliff):
"Cbio is in talks with a number of major pharmaceutical players about a licensing deal for Xtoll (CPN10), with results from the trials expected to be released in the first half of next year.
But Mr Yeates, who would not reveal which companies Cbio was in talks with, said the company would need to raise another $6m to complete the trials."
totally diffent approach from new management re information about those sniffing around.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.010(8.00%) |
Mkt cap ! $10.59M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $7.727K | 57.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42892 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 22434 | 3 |
View Market Depth
| Last trade - 10.01am 23/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |